Infant formulas containing hydrolysed protein for prevention of allergic disease.
CONCLUSIONS: We found no evidence to support short-term or prolonged feeding with a hydrolysed formula compared with exclusive breast feeding for prevention of allergic disease. Very low-quality evidence indicates that short-term use of an EHF compared with a CMF may prevent infant CMA. Further trials are recommended before implementation of this practice.We found no evidence to support prolonged feeding with a hydrolysed formula compared with a CMF for prevention of allergic disease in infants unable to be exclusively breast fed.
PMID: 30338526 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Osborn DA, Sinn JK, Jones LJ Tags: Cochrane Database Syst Rev Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Breastfed | Children | Clinical Trials | Conferences | Databases & Libraries | Dermatitis | Dermatology | Eczema | Food Allergy | General Medicine | Hay Fever | Milk | Study